Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Initial laboratory assessment should include a complete blood count and serum vitamin B 12 level
The mean concentrations of prolactin, TT, LH, and FSH were 8.8 ng/ml, 13.3 ng/dL, 7.2 IU/L, and 9.7 IU/L, respectively
The body must coordinate muscle fibers, regulate reaction time, and maintain proper form
Here is a direct BPC-157 comparison: Injectable vs Oral BPC-157 Comparison Each delivery method may fit different goals